Current perspectives in the treatment of resistant schizophrenia.
This article summarizes the current knowledge base on the diagnosis and management of treatment resistant schizophrenia. While the prevalence of treatment resistant schizophrenia is definition dependent, estimates have ranged from 30% to up to 60%. This article first looks into the various diagnostic criteria of treatment resistant schizophrenia. Then the literature is reviewed about the pharmacotherapeutics of its management. Clozapine emerges to be the gold standard. In addition risperidone and high dose olanzapine also emerge as clinically useful options. Other emerging adjunctive treatment options are equally addressed.
Solanki
R K
RK
Department of Psychiatry, Psychiatry Center, SMS Medical College, Jaipur, India.
Singh
Paramjeet
P
Munshi
Deepti
D